New treatments are in development for inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. Find out what ...

For patients with moderately to severely active ulcerative colitis, oral icotrokinra, a peptide that blocks the ...

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Eli Lilly (LLY) plans to seek Omvoh label expansion in pediatric ulcerative colitis after positive data from the Phase 3 ...

First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-R ...

Saroglitazar shows promise as a second-line treatment for primary biliary cholangitis in US and non-US patient groups.

A Cedars-Sinai-led clinical trial found that a once-daily oral medication significantly outperformed placebo in treating adults with moderate to severe ulcerative colitis. The results were published ...

Most patients in clinical response or remission with IL-23 inhibitor icotrokinra at 76 wee ...

HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...

The effect of clopidogrel monotherapy as compared with extended dual antiplatelet therapy (DAPT) with clopidogrel and aspirin beyond 12 months after implantation of a drug-eluting stent remains ...

Abdominal pain and gastrointestinal symptoms are common in diabetic ketoacidosis (DKA) and are generally reversible with metabolic correction. However, persistent or worsening abdominal findings ...

Please provide your email address to receive an email when new articles are posted on . Thunderbolt uses modulated aspiration together with standard aspiration to more consistently and completely ...